FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2373368462> ?p ?o ?g. }

• W2373368462 endingPage "72" @default.
• W2373368462 startingPage "166" @default.
• W2373368462 abstract "The effectiveness of combination therapy with conventional or pegylated interferon alpha and ribavirin in patients with chronic hepatitis C is well understood. However, the profound investigation about complications of the treatment has been rarely reported in Korea, where patients have broader spectrum of disease manifestations. The aim of this study was to evaluate the effectiveness and complications of the combination therapy of interferon alpha and ribavirin in patients with chronic hepatitis C.Two hundred and forty patients with chronic hepatitis C were included. All patients were treated with interferon alpha (3 million units thrice a week) in combination with ribavirin (800-1,200 mg, depending on body weight). Patients were treated for 6 or 12 months according to the genotypes (genotype 1; 12 months, non-1; 6 months). We retrospectively evaluated ETR (end of treatment response) and SVR (sustained virologic response) on the basis of intent-to-treat in patients completing the therapy.In 154 patients who had completed the therapy, ETR was 79.2% and SVR was 61.0%. Multivariate analysis showed that genotype and early virologic response at 3 months of treatment were independent predictive factors of SVR. Due to insufficient response, 11.3% of the patients discontinued the therapy. In addition, 24.5% of the patients prematurely discontinued the therapy due to adverse events including aggravated liver function (15.4%), failure to return (7.9%), and others (1.2%). Dose modifications of interferon alpha or ribavirin were required due to anemia (15.4%), neutropenia (8.8%), or thrombocytopenia (4.6%).The overall SVR of patients who had completed the combination therapy with interferon alpha and ribavirin was 61.0%. However, about one third of the patients discontinued the therapy prematurely due to insufficient response, adverse events and/or noncompliance." @default.
• W2373368462 created "2016-06-24" @default.
• W2373368462 creator A5000399534 @default.
• W2373368462 creator A5004474128 @default.
• W2373368462 creator A5004968431 @default.
• W2373368462 creator A5010213901 @default.
• W2373368462 creator A5010240694 @default.
• W2373368462 creator A5012526865 @default.
• W2373368462 creator A5031127358 @default.
• W2373368462 creator A5048031696 @default.
• W2373368462 creator A5053578226 @default.
• W2373368462 creator A5070006828 @default.
• W2373368462 creator A5070691621 @default.
• W2373368462 creator A5072793540 @default.
• W2373368462 creator A5081414168 @default.
• W2373368462 date "2007-03-01" @default.
• W2373368462 modified "2023-09-28" @default.
• W2373368462 title "[Effectiveness and complications of combination therapy with interferon alpha and ribavirin in patients with chronic hepatitis C]." @default.
• W2373368462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18172345" @default.
• W2373368462 hasPublicationYear "2007" @default.
• W2373368462 type Work @default.
• W2373368462 sameAs 2373368462 @default.
• W2373368462 citedByCount "4" @default.
• W2373368462 countsByYear W23733684622012 @default.
• W2373368462 countsByYear W23733684622014 @default.
• W2373368462 crossrefType "journal-article" @default.
• W2373368462 hasAuthorship W2373368462A5000399534 @default.
• W2373368462 hasAuthorship W2373368462A5004474128 @default.
• W2373368462 hasAuthorship W2373368462A5004968431 @default.
• W2373368462 hasAuthorship W2373368462A5010213901 @default.
• W2373368462 hasAuthorship W2373368462A5010240694 @default.
• W2373368462 hasAuthorship W2373368462A5012526865 @default.
• W2373368462 hasAuthorship W2373368462A5031127358 @default.
• W2373368462 hasAuthorship W2373368462A5048031696 @default.
• W2373368462 hasAuthorship W2373368462A5053578226 @default.
• W2373368462 hasAuthorship W2373368462A5070006828 @default.
• W2373368462 hasAuthorship W2373368462A5070691621 @default.
• W2373368462 hasAuthorship W2373368462A5072793540 @default.
• W2373368462 hasAuthorship W2373368462A5081414168 @default.
• W2373368462 hasConcept C126322002 @default.
• W2373368462 hasConcept C197934379 @default.
• W2373368462 hasConcept C203014093 @default.
• W2373368462 hasConcept C2522874641 @default.
• W2373368462 hasConcept C2776178377 @default.
• W2373368462 hasConcept C2776455275 @default.
• W2373368462 hasConcept C2776461080 @default.
• W2373368462 hasConcept C2776694085 @default.
• W2373368462 hasConcept C2776999253 @default.
• W2373368462 hasConcept C2777063308 @default.
• W2373368462 hasConcept C2778248108 @default.
• W2373368462 hasConcept C2780040827 @default.
• W2373368462 hasConcept C2909179924 @default.
• W2373368462 hasConcept C3020491458 @default.
• W2373368462 hasConcept C71924100 @default.
• W2373368462 hasConcept C90924648 @default.
• W2373368462 hasConceptScore W2373368462C126322002 @default.
• W2373368462 hasConceptScore W2373368462C197934379 @default.
• W2373368462 hasConceptScore W2373368462C203014093 @default.
• W2373368462 hasConceptScore W2373368462C2522874641 @default.
• W2373368462 hasConceptScore W2373368462C2776178377 @default.
• W2373368462 hasConceptScore W2373368462C2776455275 @default.
• W2373368462 hasConceptScore W2373368462C2776461080 @default.
• W2373368462 hasConceptScore W2373368462C2776694085 @default.
• W2373368462 hasConceptScore W2373368462C2776999253 @default.
• W2373368462 hasConceptScore W2373368462C2777063308 @default.
• W2373368462 hasConceptScore W2373368462C2778248108 @default.
• W2373368462 hasConceptScore W2373368462C2780040827 @default.
• W2373368462 hasConceptScore W2373368462C2909179924 @default.
• W2373368462 hasConceptScore W2373368462C3020491458 @default.
• W2373368462 hasConceptScore W2373368462C71924100 @default.
• W2373368462 hasConceptScore W2373368462C90924648 @default.
• W2373368462 hasIssue "3" @default.
• W2373368462 hasLocation W23733684621 @default.
• W2373368462 hasOpenAccess W2373368462 @default.
• W2373368462 hasPrimaryLocation W23733684621 @default.
• W2373368462 hasRelatedWork W1156217849 @default.
• W2373368462 hasRelatedWork W163112875 @default.
• W2373368462 hasRelatedWork W1963771937 @default.
• W2373368462 hasRelatedWork W1966049263 @default.
• W2373368462 hasRelatedWork W1996227777 @default.
• W2373368462 hasRelatedWork W2009358835 @default.
• W2373368462 hasRelatedWork W2015724905 @default.
• W2373368462 hasRelatedWork W2020081463 @default.
• W2373368462 hasRelatedWork W2035615422 @default.
• W2373368462 hasRelatedWork W2066441720 @default.
• W2373368462 hasRelatedWork W2086667773 @default.
• W2373368462 hasRelatedWork W2089889273 @default.
• W2373368462 hasRelatedWork W2126959573 @default.
• W2373368462 hasRelatedWork W2134935617 @default.
• W2373368462 hasRelatedWork W2164535490 @default.
• W2373368462 hasRelatedWork W2171124257 @default.
• W2373368462 hasRelatedWork W2413638841 @default.
• W2373368462 hasRelatedWork W2414348302 @default.
• W2373368462 hasRelatedWork W3031808699 @default.
• W2373368462 hasRelatedWork W3112509806 @default.
• W2373368462 hasVolume "49" @default.
• W2373368462 isParatext "false" @default.
• W2373368462 isRetracted "false" @default.

• next